Myelodysplastic syndrome and associated skin lesions: A review of the literature

Leukemia Research

Volumn 23, Issue 4, 1999, Pages 323-330

  Avivi, Irit ^a   Rosenbaum, Hanna ^a   Levy, Yishai ^a   Rowe, Jacob ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Myelodysplastic syndrome; Skin manifestations

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CLOFAZIMINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; MERCAPTOPURINE; POTASSIUM; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; SULFAPYRIDINE; TIOGUANINE; VINCRISTINE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; DERMADROME; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PYODERMA GANGRENOSUM; REFRACTORY ANEMIA; RISK ASSESSMENT; SKIN DISEASE; SKIN MANIFESTATION;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LEUKEMIC INFILTRATION; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PYODERMA GANGRENOSUM; SKIN; SWEET'S SYNDROME;

EID: 0032923945     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00161-1     Document Type: Article

References (97)

1. Doll D.C., List A.F. Myelodysplastic syndromes: introduction. Semin. Oncol. 19:1992;1.
2. Greenberg P., Bagby G. Biological rather than morphological markers in myelodysplastic syndromes. Br. J. Haematol. 53:1983;532.
3. Koeffler H.P. Myelodysplastic syndromes (preleukemia). Semin. Hematol. 23:1986;284.
4. Levine E.G., Bloomfield C.D. Leukemia and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin. Oncol. 19:1992;47.
5. Williamson P.J., Kruger A.R., Reynolds P.J., Hamblin T.J., Oscier D.G. Establishing the incidence of myelodysplastic syndrome. Br. J. Haematol. 87:1994;743.
6. Yunis J.J., Lobell M., Arnesen M.A., Oken M.M., Mayer M.G., Rydell R.E., Brunning R.D. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukemia. Br. J. Haematol. 68:1988;189.
7. Pierre R.V., Catovsky D., Mufti G.J., Swansbury G.J., Mecucci C., deWald G.W., Runtu G.W., Van den Berghe H., Rowley J.D., Mitelman F. Clinical cytogenic correlations in myelodysplasia (preleukemia). Cancer Genet. Cytogenet. 40:1989;149.
8. Sucui S., Kuse R., Weh H.J., Hossfeld D.K. Results of chromosome studies and their relation to morphology, course and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet. Cytogenet. 44:1990;15-26.
9. Heim S., Mitelman F. Chromosome abnormalities in the myelodysplastic syndromes. Clinics Haematol. 15:1986;1003.
10. Sandberg A.A. The Chromosomes in Human Cancer and Leukemia. 2nd ed. New York: Elsevier, 1990.
11. Goasguen J.E., Bennett J.M. Classification and morphologic features of the myelodysplastic syndrome. Semin. Oncol. 19:1992;4.
12. Goasguen J.E., Garand R., Bizet M., Bremond J.L., Gardais J., Callat M.P., Accard F., Chaperon J. Prognostic factors of myelodysplastic syndromes - a simplified 3-D scoring system. Leuk. Res. 14:1990;255.
13. Varela B.L., Chuang C., Woll J.E., Bennett J.M. Modification in the classification of primary myelodysplastic syndromes: the addition of a scoring system. Hematol. Oncol. 3:1985;55.
14. Greenberg P., Cox C., LeBeau L.L., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Yoyama K., Aul C., Mufti G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079.
15. Aractingi S., Bachmeyer C., Dombert H., Vignon-Pennamen D., Degos L., Dubertret L. Simultaneous occurrence of two rare cutaneous markers of poor prognosis in myelodysplastic syndrome: erythema elevatum diutinum and specific lesions (review). Br. J. Dermatol. 131:1994;112.
16. Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G., Lobell M. Refined chromosome analysis as an independent prognostic indication in de novo myelodysplastic syndromes. Blood. 67:1986;1721.
17. Jacobs R.H., Cornbleet M.A., Vardiman J.W., Larson R.A., Le Beau M.M., Rowley J.D. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 67:1986;1765.
18. Wong TY, Suster S, Bouffand D, Flynn JD, Johnson RA, Barnhill RL, Mihm MC, Jr. Histological spectrum of cutaneous involvement in patients with myelogenous leukemia including the neutrophilic dermatoses. Int J Dermatol 1995;34:323.
19. Dowd P.M., Munro D.D. Erythema elevatum diutinum. J. R. Soc. Med. 76:1983;310.
20. Doutre M.S., Beylot C., Maugein J., Boisseau A.M., Long P., Rover P., Rov C. Cutaneous injection caused by mycobacterium malmoense in a patient with myelodysplastic syndrome. J. R. Soc. Med. 86:1993;110.
21. Green A.R., Shuttleworth D., Bowen D.T., Bentley D.P. Cutaneous vasculitis in patients with myelodysplasia. Br. J. Haematol. 74:1990;364.
22. Pagliuca A., Higgens E., Samson D., Humphries S., Mufti G.J. Prodromal cutaneous vasculitis in myelodysplastic syndromes. Br. J. Haematol. 75:1990;444.
23. Watanabe R., Iijima M., Otsuka F. A case of neutrophilic dermatosis (ND) complicated by cryofibrinogenemia (CFGN) and myelodysplastic syndrome (MDS). J. Dermatol. 19:1992;181.
24. Trau N., Mozes B., Pines A., Frankl O., Schewch-Millet M., Bubis J.J. Neutrophilic dermatosis and myelodysplastic syndrome. Isr. J. Med. Sci. 23:1987;1145.
25. Reuss-Bord M.A., Pawelec G., Saal J.C., Horny H.P., Muller C.A., Waller H.D. Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br. J. Haematol. 84:1993;356.
26. Johnson M.L., Grimwood R.E. Leukocyte colony-stimulating factors: a review of associated neutrophilic dermatoses and vasculitides. Arch. Dermatol. 130:1994;77.
27. Cohen P.R., Talpaz M., Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J. Clin. Oncol. 6:1988;1887.
28. Cohen P.R., Kurznock R. Sweet's syndrome and malignancy. Am. J. Med. 82:1987;1220.
29. Kurznock R., Cohen P.R. Mucocutaneous paraneoplastic manifestations of hematologic malignancies (review). Am. J. Med. 99:1995;207.
30. Van Camp H., Van den Berg E., Timens W., Kraaijenbrink R.A., Halie M.R., Daenen S.N. Sweet's syndrome in myeloid malignancy: a report of two cases. Br. J. Haematol. 86:1994;415.
31. Bajwa R.P., Marwaha R.K., Garewal G. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in myelodysplastic syndrome. Pediatr. Haematol. Oncol. 10:1993;343.
32. Soppi E., Nousiainen T., Seppa A., Lahtinen R. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in association with myelodysplastic syndromes: a report of three cases and a review of the literature. Br. J. Haematol. 73:1989;43.
33. Varma S., Varma N., Radotra B., Garewal G., Sharma B.K. Sweet's syndrome in association with myelodysplastic syndrome. Eur. J. Haematol. 45:1990;184.
34. Sweet R.D. Further observations in acute febrile neutrophilic dermatosis. Arch. Dermatol. 103:1971;81.
35. Sweet R.D. Acute febrile neutrophilic dermatosis. Br. J. Dermatol. 100:1979;93.
36. Krolikowski F.J. Acute febrile neutrophilic dermatosa (Sweet's syndrome) associated with lymphoma. Hum. Pathol. 16:1985;520.
37. Lazarus A.A., McMillan M., Miramadi A. Pulmonary involvement in Sweet's syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukemia. Chest. 90:1986;922.
38. Crow K.D., Herdel-Vegas F., Rook A. Acute febrile neutrophilic dermatosis: Sweet's syndrome. Dermatologica. 139:1969;123.
39. Horio T., Imamura S., Danno K., Furukawa F., Ofuji S. Treatment of acute febrile neutrophilic dermatosis (Sweet's Syndrome) with potassium iodide. Dermatologica. 160:1980;341.
40. Suehisa S., Tagami H., Inoue F, Matsumoto K., Yoshikuni K. Colchicine in the treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome). Br. J. Dermatol. 180:1983;55.
41. Saxe N., Gordon W. Acute febrile neutrophilic dermatosis (Sweet's syndrome): four case reports. S. Afr. Med. J. 53:1978;253.
42. Greenberg S.J., Jegasothy B.V., Johnson R.B., Lazarus G.S. Pyoderma gangrenosum: occurrence with altered cellular immunity and circulating serum factor. Arch. Dermatol. 118:1982;498.
43. Holt P.J., Davies M.G., Saunders K.C., Nuki G. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore). 59:1980;114.
44. Prystowsky J.H., Kahn S.N., Lazarus G.S. Present status of pyoderma gangrenosum. Arch. Dermatol. 125:1989;57.
45. Basler R.S.W. Ulcerative colitis and the skin. Med. Clin. North Am. 64:1980;941.
46. Hoston J.J. Bullous pyoderma gangrenosum and multiple myeloma. Br. J. Dermatol. 10:1984;227.
47. Thompson D.M., Main R.A., Beck J.S., Albert-Recht F. Studies on a patient with leukocytoplastic vasculitis, pyoderma gangrenosum and paraproteinemia. Br. J. Dermatol. 88:1973;117.
48. Goulden V., Bond L., Highet A.S. Pyoderma gangrenosum associated with paradoxical nocturnal hemoglobinemia. Clin. Exp. Dermatol. 19:1994;271.
49. Powell F.C., Schroeter A.L., Su W.P., Perry H.O. Pyoderma gangrenosum: a review of 86 patients. Q. J. Med. 55:1985;173.
50. Yates P., Corbett G., Stockdill G. Pyoderma gangrenosum and myelodysplasia. Clin. Lab. Haematol. 9:1987;425.
51. Jacobs P., Palmer S., Gordon-Smith E.C. Pyoderma gangrenosum in myelodysplasia and acute leukemia. Postgrad. Med. J. 61:1985;689.
52. Hay C.R., Messenger A.G., Cotton D.W., Bleehen S.S., Winfield D.A. Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J. Clin. Pathol. 49:1987;387.
53. Ho K.K., Otridge B.W., Vandenberg E., Powell F.C. Pyoderma gangrenosum, polycythemia rubra vera and the development of leukemia. J. Am. Acad. Dermatol. Nov. 27:1992;804.
54. Goldstein F., Krain R., Thornton J.J. Intralesional steroid therapy of pyoderma gangrenosum. J. Clin. Gastroenterol. 7:1985;499.
55. Cave D.R., Burakoff R. Pyoderma gangrenosum associated with ulcerative colitis. Treatment with disodium cromoglycate. Am. J. Gastroenterol. 7:1985;499.
56. Wyrick W.J., Mader J.T., Butler M.E., Hulet W.H. Hyperbaric oxygen treatment of pyoderma gangrenosum. Arch. Dermatol. 114:1978;1232.
57. Johnson R.B., Lazarus G.S. Pulse therapy, therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch. Dermatol. 118:1982;76.
58. Barranco V.P. Inhibition of lysosomal enzymes by dapsone. Arch. Dermatol. 110:1974;563.
59. Michaelsson G., Molin L., Ohmann S., Gip L., Lindstrom B., Skogh M., Trolin I. Clofazimine: a new agent for the treatment of pyoderma gangrenosum. Arch. Dermatol. 112:1976;344.
60. Bulrik S., Jacobs P. Pyoderma gangrenosum in myelodysplasia responding to granulocyte macrophage-colony stimulating factor (GM-CSF). Br. J. Dermatol. 136:1997;637.
61. Penmetcha M., Navaratnam A. Pyoderma gangrenosum: response to cyclosporin A. Int. J. Dermatol. 27:1988;253.
62. August P.J., Wells G.C. Pyoderma gangrenosum treated with azothiopril and prednisone. Br. J. Dermatol. (suppl). 9:1974;80.
63. Newell L.M., Malkinson F.D. Commentary: pyoderma gangrenosum. Arch Dermatol. 118:1982;769.
64. Katz S.I., Gallin J.L., Hertz K.C., Faud A.S., Lawley T.S. Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies and successful treatment with dapsone. Medicine (Baltimore). 56:1977;443.
65. Yiannias J.A., el-Azhary R.A., Gibson L.E. Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J. Am. Acad. Dermatol. 26:1992;38.
66. Kovary P.M., Dhonau H., Happle R. Paraproteinemia in erythema elevatum diutinum. Arch. Dermatol. Res. 260:1977;155.
67. Buahene K., Hudson M., Mowat A., Smart L., Ormerod A.D. Erythema elevatum diutinum-an unusual association with ulcerative colitis. Clin. Exp. Dermatol. 16:1991;204.
68. Walker K.D., Badame A.J. Erythema elevatum diutinum in a patient with Crohn's disease. J. Am. Acad. Dermatol. 22:1990;948.
69. Tanzer F.R., Lynfield Y.L. Erythema elevatum diutinum. (letter) Arch. Dermatol. 114:1978;802.
70. De Llano M.P., Yerba M., Cabrera R., Suarez E. Myelodysplastic syndrome in association with erythema elevatum diutinum. J. Rheumatol. 19:1992;1005.
71. Goodfellow A., Calvert H. Sweet's syndrome and acute myeloid leukaemia. Lancet II 1997; 478.
72. Spector J.I., Zimbler H., Levine R., Ross J.S., Valigorsky J.M., Cole I.M. Sweet's syndrome. Association with acute leukemia. J. Am. Med. Assoc. 244:1980;1131.
73. Behm F.G., Kay S., Aportela R. Febrile neutrophilic dermatosis associated with acute leukemia. Am. J. Clin. Pathol. 76:1981;344.
74. Schiff B.L., Kern A.B., Bercovitch L. Sweet's syndrome: report of two atypical cases. Postgrad. Med. 71:1982;55.
75. Cooper P.H., Innes D.J., Greer K.E. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders. Cancer. 51:1983;1518.
76. Tikjob G., Kassis V., Thomsen H.K., Jensen G. Acute febrile neutrophilic dermatosis and abnormal bone marrow chromosomes as a marker for preleukemia. Acta. Derm. Venereol. (Stockh). 65:1985;177.
77. Sanchez F.M., Garcia A.V., Jiminez J.L.M., Perrez-Navarro A.D. Sindrome de Sweet asociado a leucosis mieloide cronica en fase proliferativa. Rev. Clin. Espanola. 177:1985;196.
78. Rouchouse B., Jaubert J., Vasselon C., Brizard C.P., Claudy A.L. Signes cutanes des anemies refractaires avec exces de blastes (AREB). Ann. Dermatol. Venereol. 113:1986;441.
79. Chevrant-Breton J., Pibouin M., Laudren A. Dermatoses neutrophiliques revelatrices d'un syndrome myelodysplastique. Ann. Dermatol. Venereol. 114:1987;1476.
80. Dereure O., Guillot B., Barneon G., Zabarino P., Guilhou J.J. Dermatoses aigues febriles a neutrophiles et hemopathies malignes: presentation d'un nouveau cas bulleux et revue de la literature. Ann. Dermatol. Venereol. 115:1988;689.
81. Meulders Q., Allal A., Eggers S., Ferrant A. Sweet's syndrome and myelodysplastic syndrome in a patient with metastatic breast carcinoma. Am. J. Med. 86:1989;138.
82. Clemmensen O.J., Menne T., Brandrup F., Thomsen K., Lange-Wantzin G. Acute febrile neutrophilic dermatosis-a marker of malignancy? Acta Derm. Venereol. (Stockh). 69:1989;52.
83. Vignon-Pennamen M.D., Wallach D. Cutaneous manifestations of neutrophilic disease. A study of seven cases. Dermatologica. 183:1991;255.
84. Takimoto C.H., Warnock M., Golden J.A. Sweet's syndrome with lung involvement. Am. Rev. Respir. Dis. 143:1991;177.
85. Komiya I., Tanoue K., Kakinuma K., Kaneda M., Shinohara T., Kuriva S., Nomura T., Saito Y. Superoxide anion hyperproduction of neutrophils in a case of myelodysplastic syndrome. Association of Sweet's syndrome and interstitial pneumonia. Cancer. 67:1992;2337.
86. Sharpe G.R., Leggat H.M. A case of Sweet's syndrome and myelodysplasia: response to cyclosporin. Br. J. Dermatol. 127:1992;538.
87. Watanabe R., Iijima M., Otsuka F. A case of neutrophilic dermatosis complicated by cryofibrinogenemia and myelodysplastic syndrome. J. Dermatol. 19:1992;181.
88. Billstrom R., Heim S., Kristofferson U., Mandahl N., Mitelman F. Structural chromosomal abnormalities of 3q in myelodysplastic syndrome/acute myeloid leukemia with Sweet's syndrome. Eur. J. Haematol. 45:1990;150.
89. Morioka N., Otsuka F., Nogita T., Igisu K., Urabe A., Ishibashi Y. Neutrophilic dermatosis with myelodysplastic syndrome: nuclear segmentation anomalies of neutrophils in the skin lesion and in peripheral blood. J. Am. Acad. Dermatol. 23:1990;247.
90. Nogita T., Morioka N., Ishibashi Y., Kawashima M., Mizoguchi M., Otsuka F. Pellagroid-like anomalous cells in the diagnosis of neutrophilic dermatosis associated with myelodysplastic syndrome. Int. J. Dermatol. 31:1992;864.
91. Mijovic A., Novack A., Medenica L. Sweet's syndrome associated with inversion of chromosome 3q in a patient with refractory anemia. Eur. J. Haematol. 49:1992;156.
92. Lesprit P., Piette A.M., Baumelou E., Epardeau B., Mignot L., Gepner P., Chapman A. Panniculitis and myelodysplasia: report of 2 cases. Eur. J. Med. 2:1993;500.
93. Fujiwara S., Hosokawa T., Akizuki S., Itami S., Yamamura T., Kuroda A., Matsunaga E., Shinkai H., Takayasu S. Lobular panniculitis terminating in acute myeloid leukemia. Int. J. Dermatol. 30:1991;503.
94. Ronnov-Jessen D., Lovgreen-Neilson P., Horn T. Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome. Bone Marr. Trans. 8:1991;413.
95. McGrath J.A., Greaves M.W., Warin A.P. Aguagenic pruritus and myelodysplastic syndrome. Am. J. Haematol. 37:1991;63.
96. Lim H.W., Cooper D., Sassa S., Dosik H., Buchness M.R., Soter N.A. Photosensitivity, abnormal porphirin profile and sideroblastic anemia. J. Am. Acad. Dermatol. Aug. 27:1992;287.
97. Lue-Aguilar J., Gonzalez-Casiro U., Mieras-Barcelo C. Disseminated porokeratosis and myelodysplastic syndrome. Dermatology. 184:1992;289.